Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/9/11/e003237.full |
| _version_ | 1819097352441430016 |
|---|---|
| author | Robin Parihar Stephen Gottschalk Ann Leen Pradip Bajgain Norihiro Watanabe Valentina Hoyos Mary K McKenna Lauren Kelly Paul Shafer Saisha A Nalawade Arushana Ali Jarrett Joubert Juan Fernando Vera Valdes |
| author_facet | Robin Parihar Stephen Gottschalk Ann Leen Pradip Bajgain Norihiro Watanabe Valentina Hoyos Mary K McKenna Lauren Kelly Paul Shafer Saisha A Nalawade Arushana Ali Jarrett Joubert Juan Fernando Vera Valdes |
| author_sort | Robin Parihar |
| collection | DOAJ |
| first_indexed | 2024-12-22T00:13:44Z |
| format | Article |
| id | doaj.art-dfbeb4bf866d41e59ad5cc0c77aedfd1 |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-12-22T00:13:44Z |
| publishDate | 2021-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-dfbeb4bf866d41e59ad5cc0c77aedfd12022-12-21T18:45:22ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262021-11-0191110.1136/jitc-2021-003237Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancerRobin Parihar0Stephen Gottschalk1Ann Leen2Pradip Bajgain3Norihiro Watanabe4Valentina Hoyos5Mary K McKenna6Lauren Kelly7Paul Shafer8Saisha A Nalawade9Arushana Ali10Jarrett Joubert11Juan Fernando Vera Valdes12Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, USABone Marrow Transplant Department, St Jude Children`s Research Hospital, Memphis, Tennessee, USACenter for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, USAMouse Cancer Genetics Program, National Cancer Institute at Frederick, Frederick, Maryland, USACenter for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, USACenter for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, USACenter for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, USACenter for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, USACenter for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, USACenter for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, USACenter for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, USACenter for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, USACenter for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, USAhttps://jitc.bmj.com/content/9/11/e003237.full |
| spellingShingle | Robin Parihar Stephen Gottschalk Ann Leen Pradip Bajgain Norihiro Watanabe Valentina Hoyos Mary K McKenna Lauren Kelly Paul Shafer Saisha A Nalawade Arushana Ali Jarrett Joubert Juan Fernando Vera Valdes Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer Journal for ImmunoTherapy of Cancer |
| title | Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer |
| title_full | Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer |
| title_fullStr | Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer |
| title_full_unstemmed | Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer |
| title_short | Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer |
| title_sort | selectively targeting myeloid derived suppressor cells through trail receptor 2 to enhance the efficacy of car t cell therapy for treatment of breast cancer |
| url | https://jitc.bmj.com/content/9/11/e003237.full |
| work_keys_str_mv | AT robinparihar selectivelytargetingmyeloidderivedsuppressorcellsthroughtrailreceptor2toenhancetheefficacyofcartcelltherapyfortreatmentofbreastcancer AT stephengottschalk selectivelytargetingmyeloidderivedsuppressorcellsthroughtrailreceptor2toenhancetheefficacyofcartcelltherapyfortreatmentofbreastcancer AT annleen selectivelytargetingmyeloidderivedsuppressorcellsthroughtrailreceptor2toenhancetheefficacyofcartcelltherapyfortreatmentofbreastcancer AT pradipbajgain selectivelytargetingmyeloidderivedsuppressorcellsthroughtrailreceptor2toenhancetheefficacyofcartcelltherapyfortreatmentofbreastcancer AT norihirowatanabe selectivelytargetingmyeloidderivedsuppressorcellsthroughtrailreceptor2toenhancetheefficacyofcartcelltherapyfortreatmentofbreastcancer AT valentinahoyos selectivelytargetingmyeloidderivedsuppressorcellsthroughtrailreceptor2toenhancetheefficacyofcartcelltherapyfortreatmentofbreastcancer AT marykmckenna selectivelytargetingmyeloidderivedsuppressorcellsthroughtrailreceptor2toenhancetheefficacyofcartcelltherapyfortreatmentofbreastcancer AT laurenkelly selectivelytargetingmyeloidderivedsuppressorcellsthroughtrailreceptor2toenhancetheefficacyofcartcelltherapyfortreatmentofbreastcancer AT paulshafer selectivelytargetingmyeloidderivedsuppressorcellsthroughtrailreceptor2toenhancetheefficacyofcartcelltherapyfortreatmentofbreastcancer AT saishaanalawade selectivelytargetingmyeloidderivedsuppressorcellsthroughtrailreceptor2toenhancetheefficacyofcartcelltherapyfortreatmentofbreastcancer AT arushanaali selectivelytargetingmyeloidderivedsuppressorcellsthroughtrailreceptor2toenhancetheefficacyofcartcelltherapyfortreatmentofbreastcancer AT jarrettjoubert selectivelytargetingmyeloidderivedsuppressorcellsthroughtrailreceptor2toenhancetheefficacyofcartcelltherapyfortreatmentofbreastcancer AT juanfernandoveravaldes selectivelytargetingmyeloidderivedsuppressorcellsthroughtrailreceptor2toenhancetheefficacyofcartcelltherapyfortreatmentofbreastcancer |